Bio-Techne
TECH
#2174
Rank
S$11.67 B
Marketcap
S$74.61
Share price
1.86%
Change (1 day)
-10.19%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2025 (TTM): S$0.68

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is S$0.66. In 2024 the company made an earnings per share (EPS) of S$1.26 a decrease over its 2023 EPS that were of S$1.80.

EPS history for Bio-Techne from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$0.68-46.31%
2024S$1.26-29.58%
2023S$1.80-14.97%
2022S$2.1124.16%
2021S$1.7017.98%
2020S$1.44-10.94%
2019S$1.62101.57%
2018S$0.80-16.99%
2017S$0.9745.02%
2016S$0.67-20.97%
2015S$0.84-14.97%
2014S$0.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
S$22.47 3,317.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
S$7.04 971.15%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
S$10.39 1,480.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
S$6.41 875.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
S$2.49 278.27%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
S-$0.27-140.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
S-$30.74-4,775.00%๐Ÿ‡บ๐Ÿ‡ธ USA